Source:http://linkedlifedata.com/resource/pubmed/id/10489210
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
9
|
| pubmed:dateCreated |
1999-10-19
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
0931-0509
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
14
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2079-81
|
| pubmed:dateRevised |
2005-11-16
|
| pubmed:meshHeading |
pubmed-meshheading:10489210-Antiviral Agents,
pubmed-meshheading:10489210-Drug Combinations,
pubmed-meshheading:10489210-Hepatitis C,
pubmed-meshheading:10489210-Humans,
pubmed-meshheading:10489210-Interferon-alpha,
pubmed-meshheading:10489210-Kidney Failure, Chronic,
pubmed-meshheading:10489210-Nephrology,
pubmed-meshheading:10489210-Ribavirin
|
| pubmed:year |
1999
|
| pubmed:articleTitle |
Combination of interferon alpha and ribavirin in the treatment of hepatitis C: implications for the clinical nephrologist.
|
| pubmed:publicationType |
Editorial,
Review
|